SLU7 and myelodysplastic syndrome: Splicing factor mutations show variable impact; SF3B1 mutations demonstrate conflicting ESA response data, while cohesin complex mutations, specifically STAG2 (an X-linked gene), are significantly associated with ESA resistance in male LR-MDS patients [15,16].